Moneycontrol PRO
lincoln pharmaceuticals
Jump to
45 Results Found
  • Lincoln Pharma earmarks around Rs 30 crore for expansion of Cephalosporin products portfolio Sep 21, 2021 02:07 PM IST

    Lincoln Pharma earmarks around Rs 30 crore for expansion of Cephalosporin products portfolio

    The company has also acquired a facility in Mehsana for this, and expects the commercial operations from the plant to start from March 2022, Lincoln Pharmaceutical said in a regulatory filing.

  • Lincoln Pharma Standalone June 2021 Net Sales at Rs 119.74 crore, up 18.51% Y-o-Y Aug 10, 2021 05:00 PM IST

    Lincoln Pharma Standalone June 2021 Net Sales at Rs 119.74 crore, up 18.51% Y-o-Y

  • Lincoln Pharma Consolidated March 2021 Net Sales at Rs 79.58 crore, up 1.42% Y-o-Y May 26, 2021 02:00 PM IST

    Lincoln Pharma Consolidated March 2021 Net Sales at Rs 79.58 crore, up 1.42% Y-o-Y

  • Lincoln Pharma Standalone March 2021 Net Sales at Rs 77.54 crore, up 3.03% Y-o-Y May 26, 2021 01:44 PM IST

    Lincoln Pharma Standalone March 2021 Net Sales at Rs 77.54 crore, up 3.03% Y-o-Y

  • Lincoln Pharma Consolidated December 2020 Net Sales at Rs 114.75 crore, up 16.47% Y-o-Y Feb 02, 2021 03:00 PM IST

    Lincoln Pharma Consolidated December 2020 Net Sales at Rs 114.75 crore, up 16.47% Y-o-Y

  • Lincoln Pharma Standalone December 2020 Net Sales at Rs 112.19 crore, up 17.31% Y-o-Y Feb 02, 2021 03:00 PM IST

    Lincoln Pharma Standalone December 2020 Net Sales at Rs 112.19 crore, up 17.31% Y-o-Y

  • Lincoln Pharma Standalone March 2020 Net Sales at Rs 75.26 crore, down 2.84% Y-o-Y Jun 26, 2020 09:45 AM IST

    Lincoln Pharma Standalone March 2020 Net Sales at Rs 75.26 crore, down 2.84% Y-o-Y

  • Lincoln Pharma Standalone March 2019 Net Sales at Rs 77.46 crore, up 6.85% Y-o-Y May 30, 2019 01:30 PM IST

    Lincoln Pharma Standalone March 2019 Net Sales at Rs 77.46 crore, up 6.85% Y-o-Y

  • Lincoln Pharma Consolidated March 2019 Net Sales at Rs 79.32 crore, up 17.8% Y-o-Y May 30, 2019 01:12 PM IST

    Lincoln Pharma Consolidated March 2019 Net Sales at Rs 79.32 crore, up 17.8% Y-o-Y

  • Lincoln Pharma Consolidated December 2018 Net Sales at Rs 84.43 crore, up 5.3% Y-o-Y Feb 12, 2019 04:18 PM IST

    Lincoln Pharma Consolidated December 2018 Net Sales at Rs 84.43 crore, up 5.3% Y-o-Y

  • Lincoln Pharma Standalone December 2018 Net Sales at Rs 81.00 crore, up 7.21% Y-o-Y Feb 12, 2019 04:18 PM IST

    Lincoln Pharma Standalone December 2018 Net Sales at Rs 81.00 crore, up 7.21% Y-o-Y

  • Lincoln Pharma Standalone September 2018 Net Sales at Rs 97.95 crore, up 14.38% Y-o-Y Nov 14, 2018 01:12 PM IST

    Lincoln Pharma Standalone September 2018 Net Sales at Rs 97.95 crore, up 14.38% Y-o-Y

  • Lincoln Pharma Consolidated September 2018 Net Sales at Rs 102.60 crore, Up 14.44% Y-o-Y. Nov 14, 2018 01:11 PM IST

    Lincoln Pharma Consolidated September 2018 Net Sales at Rs 102.60 crore, Up 14.44% Y-o-Y.

  • Lincoln Pharma gets patent for anti-malarial drug Dec 19, 2017 12:37 PM IST

    Lincoln Pharma gets patent for anti-malarial drug

    The patent has been awarded by the Indian government for an Arteether injection to treat malaria, according to a BSE filing.

  • Lincoln Pharma surges 20%; what's driving the stock up? Feb 28, 2017 04:51 PM IST

    Lincoln Pharma surges 20%; what's driving the stock up?

    The research house cites the company‘s capability to increase market share by widening portfolio through product launches, expanding geographies and undertaking large job contracts.

  • Lincoln Pharma delists from Ahmedabad Stock Exchange Nov 28, 2016 02:22 PM IST

    Lincoln Pharma delists from Ahmedabad Stock Exchange

    Lincoln Pharmaceuticals has delisted its shares from Ahmedabad Stock Exchange Limited (ASEL), the company today.

  • Market size of Lincoln Pharma's oral spray is Rs 300 crore: MD Sep 23, 2016 11:34 AM IST

    Market size of Lincoln Pharma's oral spray is Rs 300 crore: MD

    Recently, Lincoln Pharmaceuticals launched Ondansetron oral spray. It is for treatment of nausea and vomiting caused by surgery or cancer drugs, in the Indian market. Speaking to CNBC-TV18 Rajni Patel, Joint MD, Lincoln Pharma said that the Ondansetron market size is Rs 300 crore. He also spoke about net profit and products in pipeline.

  • Lincoln Pharma consolidated Jun '16 sales at Rs 92.69 crore Aug 12, 2016 04:21 PM IST

    Lincoln Pharma consolidated Jun '16 sales at Rs 92.69 crore

    Lincoln Pharmaceuticals has reported a consolidated total income from operations of Rs 92.69 crore and a net profit of Rs 10.93 crore for the quarter ended Jun '16

  • Expect growth to continue going forward: Lincoln Pharma Aug 11, 2016 04:05 PM IST

    Expect growth to continue going forward: Lincoln Pharma

    In an interview to CNBC-TV18, Mahendra Patel, MD of Lincoln Pharmaceuticals spoke about the results and his outlook for the company.

  • Here are a few investment ideas from Prakash Diwan Jul 12, 2016 09:00 AM IST

    Here are a few investment ideas from Prakash Diwan

    In an interview to CNBC-TV18, Prakash Diwan, Investment Evangelist at prakashdiwan.in shared his readings and outlook on specific stocks and sectors.

  • Six in Sixty: Stocks you should keep on your radar Mar 16, 2016 03:20 PM IST

    Six in Sixty: Stocks you should keep on your radar

    CNBC-TV18's Ekta Batra lists out stocks that you should focus on – Hindalco, Vedanta, Bajaj Auto, ITC, BPCL, GAIL, Cairn India, Lupin, Wockhardt, Marksans Pharma, Lincoln Pharmaceuticals

  • Lincoln Pharma consolidated Dec '15 sales at Rs 107.96 crore Feb 12, 2016 10:14 AM IST

    Lincoln Pharma consolidated Dec '15 sales at Rs 107.96 crore

    Lincoln Pharmaceuticals has reported a consolidated total income from operations of Rs 107.96 crore and a net profit of Rs 6.44 crore for the quarter ended Dec '15

  • Exit Lincoln Pharma, prefer Syngene: Gaurang Shah Jan 22, 2016 02:56 PM IST

    Exit Lincoln Pharma, prefer Syngene: Gaurang Shah

    Gaurang Shah of Geojit BNP Paribas Financial Services is of the view that one may exit Lincoln Pharma.

  • Bull's Eye: Buy SpiceJet, KPIT, I'bulls Real; sell UPL, HDIL Jan 21, 2016 09:49 AM IST

    Bull's Eye: Buy SpiceJet, KPIT, I'bulls Real; sell UPL, HDIL

    Krish Subramanyam of Altamount Capital is of the view that one may buy Apollo Tyres with a target of Rs 141.

  • Top buzzing midcap stocks to trade on January 19 Jan 19, 2016 01:22 PM IST

    Top buzzing midcap stocks to trade on January 19

    Here are a few top buzzing midcap stocks picked by CNBC-TV18's analysts in trade today. We have - HCL Tech, Asian Paints, Rallis India, Tata Metaliks, Hindustan Oil Exploration Company (HOEC), Bharat Bijlee, Mindtree, Lincoln Pharmaceuticals.

Sections
ISO 27001 - BSI Assurance Mark